Skip to main content
FinSpry Logo
FinSpry
IMRX logo
IMRX
(NASDAQ)
Immuneering Corporation
$5.45-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Immuneering (IMRX) Stock Price & Financial Analysis

Immuneering Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$5.19 - $5.59
52-Week High$10.08
52-Week Low$1.10
Open$5.19
Volume596.52K
Average Volume (3M)596.52K
Market Cap239.86M
Shares Outstanding44.01M
Price to Book (P/B)1.07
EV/EBITDA-1.86
50-Day MA$5.07
200-Day MA$5.45
52-Week Change255.33%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Immuneering

What is the current stock price for IMRX?

As of the latest trading session, IMRX stock trades at $5.45. The 52-week range is $1.10–$10.08, with a day range of $5.19–$5.59.

What is the P/E ratio for IMRX?

The P/E ratio (Price-to-Earnings) for IMRX is shown in the Key Statistics section. This valuation metric helps compare Immuneering Corporation to industry peers.

Does IMRX pay dividends?

Immuneering does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IMRX?

Based on 2 analysts, the consensus for IMRX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of IMRX?

Immuneering's market capitalization is $239.9M, classifying it as a micro-cap company. Immuneering operates in the Healthcare sector within the Biotechnology industry.